首页 | 本学科首页   官方微博 | 高级检索  
     


Muscle involvement in Dent disease 2
Authors:Eujin Park  Hyun Jin Choi  Jiwon M. Lee  Yo Han Ahn  Hee Gyung Kang  Yoo Mee Choi  Se Jin Park  Hee Yeon Cho  Yong-Hoon Park  Seung Joo Lee  Il Soo Ha  Hae Il Cheong
Affiliation:1. Department of Pediatrics, Seoul National University Children’s Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 110-744, Korea
2. Research Coordination Center for Rare Diseases, Seoul National University Hospital, Seoul, Korea
3. Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea
4. Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea
5. Department of Pediatrics, Samsung Medical Center, Seoul, Korea
6. Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea
7. Department of Pediatrics, Ehwa University Mokdong Hospital, Seoul, Korea
8. Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
Abstract:

Background

Dent disease, an X-linked recessive renal tubulopathy, is caused by mutations in either CLCN5 (Dent disease 1) or OCRL (Dent disease 2). OCRL mutations can also cause Lowe syndrome. In some cases it is difficult to differentiate Dent disease 1 and 2 on the basis of clinical features only without genetic tests. Several studies have shown differences in serum levels of muscle enzymes between these diseases. The aim of our study was to test the validity of these findings.

Methods

In total, 23 patients with Dent disease 1 (Group A), five patients with Dent disease 2 (Group B) and 19 patients with Lowe syndrome (Group C) were enrolled in our study. The serum levels of three muscle enzymes [creatine phosphokinase (CPK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST)], were measured. The levels of a hepatic enzyme, alanine aminotransferase (ALT), were also measured as a control.

Results

One patient in Group B had muscle hypoplasia of both upper extremities. The serum levels of all three muscle enzymes assayed were higher in Group B or C patients than in Group A patients. Serum ALT levels were normal in all three groups of patients.

Conclusions

The serum levels of muscle enzymes in patients with Dent disease can be used as a biomarker to predict genotypes, even though the patients do not have clinical symptoms of muscle involvement.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号